chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received vaccine, still get shingles/Suspected vaccination failure; shingles; pain is still terrible; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 03-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received the Shingles vaccine and still get shingles often. The symptoms did not last as long, but the pain was still terrible. Additional supportive information: This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown. The follow up would not possible as no contact details were available.
Developed postpartum pre-eclampsia with severe features after delivering my daughter at 41 weeks. My due date was 10/4 and I delivered late on another date. Birth weight was 7 lbs 8 oz. This was my 4th pregnancy, never had BP complications before this one. Was readmitted to the hospital 6 days after delivering and placed on magnesium drip for 24 hours . I have since recovered from The acute event but still Do not feel completely normal.
Headaches, starting the day of the COVID vaccine, continuing every day since that vaccine (through my last conversation with patient on 09/29/2021).   One week after the same vaccine, total vision loss in both eyes occurred, lasting approximately ten minutes.  Subsequently, a similar transient vision loss event occurred three additional times.  On 09/29/2021, patient visited hospital urgently for her first ever seizure.
This case meets criteria for vaccine breakthrough review.  Sx include fever and chills, cough.
Patient got vaccine around 10:06AM reporting minor dizziness regarding to the 1st dose. Around 5 minutes into the next wait period, patient was found sitting on the floor eating snacks. When asked why, patient states that she felt very dizziness to the point of not being able to drive home during the wait period. Patient did report similar conditions after giving blood and not eating (patient reports not eating anything prior to vaccination). Possibly this adverse event could be just the patient not eating, but I'm reporting it just in case.
After getting the vaccine I got a fever and was real achy.  I had joint pain which I associated with my Lyme's disease. I had inflammation in all the joints and pain, like tendonitis. After some weeks I had to take some pain medication, which I had not to take for a couple of years. I assume it was a bug that was going around. I was feeling pretty bad and I went to the ER. They gave me some medicine to settle my stomach, they tested me for Covid-19 because I had been exposed and the test came back negative. As far as I know it was a virus. I still have muscle spasms and inflammation.
This spontaneous report was received from a physician regarding to a 24 year old female patient. No concurrent condition and historical medication was reported. On an unknown date, the patient was vaccinated with MMR II as a child. No concomitant medication was reported. On 17-APR-2015, the patient titers were drawn the titers showed that the patient had immuity to the MMR II, however the Measles titer came back negative. No product quality complaint was involved. The outcome of measles antibody negative was unknown. Causality between event and MMR II, live was unknown. Additional information has been requested.
my blood pressure rose to over 180; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (my blood pressure rose to over 180) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (my blood pressure rose to over 180). At the time of the report, BLOOD PRESSURE INCREASED (my blood pressure rose to over 180) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 180 (High) Rose to over 180.         No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-403137 (Patient Link).
This spontaneous report was received from a Registered nurse regarding a 20 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 01-AUG-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis (product storage error). No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-1804USA005153.
Within an hour of getting the shots I came home, added a hat and garden gloves to my winter jacket and began cutting down flowers in my garden to clear for winter. After about 20 minutes working in 43 degree temperature with wind, I felt "frozen" and rushed inside. I was so cold I began crying and then shriking in pain I was so cold. I was afraid the neighbors whould break in to see what was wrong. I was bent over just trying to get warm. Turned on my gas fireplace and turned up heat. Reaction lasted 1hr. Tried calling store and Dr. suggested 911, didn't like that idea... I laid down on the couch and covered myself with a warm blanket. I was still crying, shrieking, teeth chattering and shaking crazy
crying-high pitched;unconsoled-didn't go to MD,called nurse&was told was OK
Vaccine administered Wed. 8/13/03 am. On Thursday pt was lethargic and achy in joints and muscles entire body. Shoulder was swollen, hot and red, Thursday evening and Friday these symptoms continued and detected a fever of 100 deg F both days. AFter 2 days no fever, arm, still sore/red at site on 8/18/03.
4/10/2021 started with bloody nose & dry cough. Still with symptoms today.
Client presented to the vaccination site on 01/14/2022for COVID 19 vaccine booster. The client notified PHN that he received both primary doses of Moderna COVID 19 vaccine and showed vaccine card for verification. Client reports having a "swollen throat" and "had a hard time breathing" during the 15 minute observation period after the first dose of Moderna COVID 19 Vaccine received on 04/13/2021 at a community clinic. Client reports the staff said "it should go away." Client reports no side effects noticed with second vaccine, and discussed not reporting adverse reaction at second vaccination appointment.  PHN text Vaccine Operations Lead, consult at 8:45am. At 8:54 am Dr. approved client to receive Janssen COVID 19 vaccine for booster dose today via text message. . Client received Janssen COVID 19 vaccine lot # 1855191 exp: 4/11/22 at 10:57 am in right deltoid. The client did not report any symptoms during the 30 minute observation period. PHN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 12:20 pm with steady gait.
My entire left arm is painful with erythema, warmth at site, bruising, joint pain, left jaw pain, headache, muscle aches, and swollen/tender lymph nodes. The site on the first day 3/16/17, about 2 hours after injection, was 1x2cm with redness and bruising; 2nd day, 3/17/16 when I saw a physician it was 2x4cm- red, puffy, hot, burning, and headache; 3rd day, 3/18/17 it was 4x6cm (saw another physician) plus all same symptoms plus swollen glands and neck/ear/jaw pain; and today, 3/19/17 it is 7x9cm with all same symptoms plus my entire left arm is heavy, achy, and painful.
feeling cold; Nausea; Chills; Headache; Fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.            Concomitant product use was not provided. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Added event onset date.
Sore throat, headache, dizziness, body aches, back pain, fever, fatigue. Used acetaminophen to reduce fever.
Patient was given the second dose of VAQTA one month from the first dose. The first dose was given 01/20/2017 and second dose 02/21/2017. Per CDC the second dose must be given at least 6 months from the second dose. Patient did not report any adverse affects and cannot be reached at this time.
12 hours after I got the vaccine I experienced severe body aches, chills, fever, nausea, fatigue, and loss of appetite. These severe symptoms lasted for 35 hour. It has now been over a week since I received my booster and I am experiencing loss of appetite, constant nausea, migraines, bloodshot eyes when my migraine is there, pretty intense fatigue, and random body aches.
Rash on chest, itching, right breast dark pink. Today - 6 months later - random itching on chest, right breast very pale pink, looks like heat rash changes from light to lighter pink
Presented for weakness, chills, Arthralgia. MD states no PMH. Admit for severe COVID PNA, hypoxia, rhabdo and coagulopathy d/t COVID. Tx w/O2, steroid, abx, no remdesivir d/t AKI. DC to acute rehab on 2L O2.
No additional adverse events reported; has missed her third dose; Information has been received from a female patient of unknown age referring to herself. Information about concurrent condition, concomitant medication, drug reactions/allergies and medical history was not provided.  The patient reported that she received her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot# and expiration date were not reported) for prophylaxis in February 2021 at the age of 22 years old and received her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot# and expiration date were not reported) for prophylaxis in August 2021.      The patient reported that she has missed her third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) in December 2021. No additional adverse events or further details were reported.
Received vaccination.  Blisters on legs.  MMR, Hep AV, Varivax, Prevnar.  Blister both thighs size 1 cm.
w/in 24 hrs p/vax pt exp bruising & pain @ inject site; on exam 2 months p/vax pt had SQ atrophy @ site 4cm x 1/2" wide depression w/bruising; during wk of vax pt recvd steriod in lt deltoid for allergy;
Swollen lymph node in left armpit tennis ball size- pain meds, cold compress, heat compression non treatment helps Fever, headache, leg cramps-?treated with Tylenol
Headache; tiredness; sore arm at injection site; generally feel unwell,; Chills; upset stomach; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Batch/Lot Number: EN 6198), via an unspecified route of administration, administered in Arm Left on 01Mar2021 16:30 () as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included coeliac disease, asthma, hypothyroidism, polycythaemia bradycardia from an unknown date and unknown if ongoing and Allergy to wheat, yeast, orange peel, high fructose corn syrup, material used in stress tests and wheat, yeast, orange peel, high fructose corn syrup, material used in stress tests from an unknown date and unknown if ongoing. Concomitant medication(s) included Breo, Albuterol, Synthroid, Omeprazole taken for an unspecified indication, start and stop date were not reported. On unspecified date the patient previously took morphine and experienced drug hypersensitivity. On 01Mar2021 the patient experienced headache, tiredness, sore arm at injection site, generally feel unwell, chills and upset stomach. The patient did not receive any vaccine prior four week of COVID-19 vaccination. Patient not diagnosed with COVID-19 before vaccination and since vaccination patient not tested for covid-19. Patient did not received treatment for the events. The outcome of the event was reported as recovering.   No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a healthcare worker refers to an unspecified patients fo unknown age and gender. Since on an unknown date in March 2015, the unspecified patients were vaccinated with improperly stored VAQTA (lot# K012457 and expiry date: 04-JUN-2017) (dose and frequency were not reported) for an unknown indication. No adverse effects were reported. No product quality complaint was reported for VAQTA. This is one of the several reports from the same reporter. Additional information has been requested.
PT STATES THAT SHE WAS FEELING WEIRD . PT WAS PALE, STARTED SHAKING AND SAYING THAT SHE WAS GOING TO PASS   OUT. PT SLUMPED IN HER CHAIR, SUPPORTED BY 2 RNS, PT UNABLE TO ANSWER PROMPTS. PT TRANSFERRED TO ED. BEDSIDE VITALS IN OBSERVATIONBP 90/66 HR 79
Red-purplish raised cluster around injection sites, itchy, sore occurring 1 day after injection. By 3 days, soreness abating, hard lump seeming to dissolve with color. Ice helpful
strong body aches; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist).  An elderly male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 26Sep2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 27Sep2023, outcome "recovered" (28Sep2023), described as "strong body aches". It was unknown if therapeutic measures were taken as a result of pain.  Additional information: It was unknown if the patient had any known allergies and other medical history. It was unknown if the patient received any other vaccine within four weeks. Prior vaccination, it was unknown if the patient had COVID-19 while post vaccination, it was unknown if patient was tested for COVID-19. Patient had strong body aches on the next day of vaccination that resolved the next day by around 15:00. Patient was not able to provide additional details about the administration or vaccination history and did not want to be contacted. Other information is not known.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound Covid-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 29Aug2022 to 03Sep2022.  based on this Anti-viral details: Product: COVID 19 Treatment, Brand: Paxlovid, Treatment start date: 29Aug2022, Treatment stop date: 03Sep2022, Indication: Treatment of COVID-19  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Narrative:  swollen red spot at injection site, tender/firmness to the whole arm, painful at 7/10. Denies n/v/f but hurts to move the arm. Hurts too much to move the arm at all. Fingers are able to move. The muscles cramping in the arm is having slight tremors in the arm. Denies redness or swelling to the arm. Denies facial lip or tongue swelling, no rash or itching. Has slight headache no problem with breathing.
Extreme nasal drainage  Extreme pressure when bending over or trying to exercise  Bad cramps in abdomen
Hernia.; This is a spontaneous report received from a contactable consumer.   A male patient of unspecified age received of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), unspecified route of administration on an unspecified date as a dose1, single for COVID-19 immunization. The patient medical history and concomitant were not reported. The patient experienced hernia (medically significant) on an unspecified date. The Patient husband had the first dose of the Pfizer COVID-19 vaccine and is scheduled for the second dose on 04Mar2021. He recently had a hernia repair after the first dose. Yesterday (25Feb2021), he went to his doctor and was prescribed with doxycycline. Patient wanted to know if that would affect the vaccine that he is taking on 04Mar2021. Therapeutic measures were taken as a result of hernia includes doxycycline. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
General body aches, fever to 101.3, chills, severe pain & weakness with some swelling in both legs; walking limited. Reaction began Fri, 10/22, improvement began Tues, 10/26. Took Ibuprofen & fluids.
pt in ED with c/o cough and dyspnea; hx of hypoxia and uses supplemental O2 at home prn; O2 sats in the 70s; placed on BiPAP; diagnosed with COVID pneumonia, acute and chronic HRF; pt's condition declined; placed on comfort care measures; pt expired in the hospital
Patient felt faint/ pale in color and she stated she could not hear. Patient had a slight jerk of movement and had to be laid down. Lab test were normal.
Left groin pain then so bad needed a walker to walk short distances. Severe pain into thigh to knee. Leg would give out. Also numb from groin to knee. Also very gassy burping and flatulence with upset stomach.
On 8/3, patient was admitted to an outside hospital with fever and cough. ESRD on hemodialysis. Was on oxygen and received remdesivir and dexamethasone x 1 day . Off oxygen on 8/4. Admitted to our hospital on 8/9 with worsening shortness of breath and generalized weakness with fever and chills. No improvement since discharge from outside hospital. Placed on 5L NC. Started on ceftriaxone, azithromycin, dexamethasone and remdesivir. Patient improved over hospitalization course. Discharged on 8/24/2
pt c/o gen fatigue, rhinorrhea, ST & anterior cervical lymphadenopathy x 5 days following the immun;also has had arthralgias;
p/vax pt exp a stroke;pt seen in ER & hosp;tx, physical findings & test results were not provided;no outcome of event reported;
Information has been received from a physician concerning a 22 year old female with no pertinent medical history and no allergies, who on 8/30/06 was vaccinated with HPV rL1 6 11 16 18 VLP vaccine yeast. On 9/2/06 the pt developed a canker sore on her lip and sore throat. On 9/6/06 she experienced nausea, vomiting, malaise, a temperature of 102F and developed a herpetic ulcerative ring on her left ring finger. It was also reported that the pt experienced myalgia. Unspecified medical attention was sought/ Subsequently, it was reported on 9/8/06 that the symptoms were subsiding, the lesion on the pts lip had crusted and her temp was 98.9F. 01/05/2007 Follow up information received stated that on 02-SEP-2006 the patient also developed gastrointestinal upset. Lab work completed on 13-SEP-06 included positive cultures for Herpes simplex type 1 isolated in oral swab and on the patients finger. At the time of this report it was unknown if the patient had recovered from the event. Additional information has been requested.
covid19-like symptoms; 1st dose 2nd of feb/Wanted to get the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (covid19-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (covid19-like symptoms) (seriousness criterion hospitalization) and PRODUCT DOSE OMISSION ISSUE (1st dose 2nd of feb/Wanted to get the 2nd dose). At the time of the report, SUSPECTED COVID-19 (covid19-like symptoms) and PRODUCT DOSE OMISSION ISSUE (1st dose 2nd of feb/Wanted to get the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.  Patient stayed a long time in the Hospital and after that in a rehab center.  Very limited information regarding the event has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the event has been provided at this time.  Further information has been requested.
Patient stated arm became very red and swollen near the injection site. Also became very stiff and sore.
Patient had received Moderna for initial covid vaccinations and received Pfizer for the booster/3rd injection.